By Mauro Orru
The European Union gave International Flavors & Fragrances the go-ahead to sell its pharma solutions business to French company Roquette for up to $2.85 billion, saying the deal wouldn't stifle competition in the bloc.
The European Commission, the EU's executive arm, said it cleared the deal because IFF and privately-owned Roquette aren't close competitors, adding that the French group would continue to compete with a sufficient number of rivals following the transaction.
New York-based IFF agreed last year to sell the unit to Roquette in a deal that would hand it 10 research-and-development and production sites and roughly 1,100 employees.
IFF's pharma solutions business develops pharmaceutical excipients, substances other than the active pharmaceutical ingredient present in a drug formulation. The unit made about $1 billion in revenue in 2023.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
February 18, 2025 07:25 ET (12:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.